Adapthealth Corp (AHCO)vsBoston Scientific Corp (BSX)
AHCO
Adapthealth Corp
$5.64
+1.26%
HEALTHCARE · Cap: $761.77M
BSX
Boston Scientific Corp
$43.92
-1.70%
HEALTHCARE · Cap: $64.66B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 524% more annual revenue ($21.00B vs $3.36B). BSX leads profitability with a 17.5% profit margin vs -6.8%. BSX earns a higher WallStSmart Score of 72/100 (B).
AHCO
Hold47
out of 100
Grade: D+
BSX
Strong Buy72
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+67.3%
Fair Value
$32.23
Current Price
$5.64
$26.59 discount
Margin of Safety
-14.4%
Fair Value
$39.06
Current Price
$43.92
$4.86 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 22.9%
Generating 1.3B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 0.8%
Elevated debt levels
ROE of -16.6% — below average capital efficiency
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AHCO
The strongest argument for AHCO centers on Price/Book. Revenue growth of 12.7% demonstrates continued momentum.
Bull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Price/Book. Profitability is solid with margins at 17.5% and operating margin at 22.9%. PEG of 0.63 suggests the stock is reasonably priced for its growth.
Bear Case : AHCO
The primary concerns for AHCO are Market Cap, Operating Margin, Debt/Equity.
Bear Case : BSX
The primary concerns for BSX are Altman Z-Score.
Key Dynamics to Monitor
AHCO profiles as a turnaround stock while BSX is a mature play — different risk/reward profiles.
AHCO carries more volatility with a beta of 1.39 — expect wider price swings.
AHCO is growing revenue faster at 12.7% — sustainability is the question.
BSX generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (72/100 vs 47/100), backed by strong 17.5% margins. AHCO offers better value entry with a 67.3% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Adapthealth Corp
HEALTHCARE · MEDICAL DEVICES · USA
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
Visit Website →Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?